Form 4: Labcorp EVP Reports Routine Stock Transactions

Labcorp's EVP and CHRO, Anita Z. Graham, reported the vesting of restricted stock units and subsequent tax-related stock dispositions.

Summary

• Anita Z. Graham, EVP, CHRO of Labcorp Holdings Inc., reported multiple transactions involving company common stock and restricted stock units (RSUs).
• On February 6, 2026, 327 Restricted Stock Units vested, resulting in the acquisition of 327 shares of common stock.
• Concurrently on February 6, 2026, 119 shares of common stock were disposed of at a price of $277.20 to cover tax withholding obligations.
• On February 7, 2026, 367 Restricted Stock Units vested, leading to the acquisition of 367 shares of common stock. These RSUs were part of a grant that began vesting on February 7, 2024, and are now fully vested.
• On February 9, 2026, 112 shares of common stock were disposed of at a price of $274.01 to satisfy tax withholding obligations.
• Following these transactions, Anita Z. Graham beneficially owns 1,213 shares of common stock and holds 1,397 unvested Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions related to executive compensation and tax obligations, which are standard practice and do not indicate a change in company fundamentals or outlook.

Positives

• Vesting of Restricted Stock Units indicates continued equity participation and alignment of executive interests with shareholders.
• The executive continues to hold a significant number of shares and unvested RSUs, demonstrating ongoing commitment to the company.

Negatives

• Dispositions of common stock occurred to cover tax withholding obligations, which is a routine event following RSU vesting and not indicative of a negative outlook.

Future Outlook

The filing is a disclosure of past transactions and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those reported in this Form 4, are common occurrences in publicly traded companies like Labcorp Holdings Inc. They reflect standard executive compensation practices involving equity awards and subsequent tax obligations. These types of filings typically do not indicate significant shifts in broader industry trends or competitive landscape but rather reflect individual executive compensation events.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) as part of executive compensation is a widespread industry standard across various sectors, including healthcare and diagnostics, where Labcorp operates.
• Companies like Quest Diagnostics (DGX) and other large healthcare providers also utilize similar equity compensation structures to align executive incentives with long-term shareholder value.
• The disposition of shares to cover tax withholding upon vesting is also a standard and expected practice, consistent with how equity awards are managed across the S&P 500.

Corporate Governance

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation, aligning management's interests with long-term shareholder value through equity ownership.
• Employees: No direct impact on general employees is indicated.

Next Steps

• The remaining 1,397 unvested Restricted Stock Units will continue to vest according to their respective schedules.

Key Dates

Keywords

Labcorp Holdings Inc., LH, Form 4, insider trading, stock transactions, restricted stock units, RSU vesting, executive compensation, Anita Z. Graham, beneficial ownership, tax withholding